Rare diseases
Investigational molecules
Locations
Back to France990 clinical trials in STRASBOURG, Alsace, France across 6 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Phase III trial evaluating ianalumab with background drug combination in patients with Sjögren's disease
FranceAdjuvant Datopotamab Deruxtecan with Drug Combination in Patients with High‑Risk Muscle‑Invasive Urothelial Carcinoma
FranceEfficacy of Tree SLIT-tablet and Betula pendula pollen extract in adolescents (12‑17) with allergic rhinitis/rhinoconjunctivitis caused by birch pollen
FranceStudy of Beclometasone Dipropionate in Patients with Asthma to Evaluate Disease Characteristics and Control
FranceEfficacy and safety of osilodrostat with drug combination in patients with hypertension caused by Cushing's syndrome
FranceLong‑term Safety of Adagrasib with Drug Combination in Adults with Solid Tumors
FranceA double‑blind, placebo‑controlled trial of oral BI 1015550 in patients with systemic sclerosis
FranceSwitching to lenacapavir-based drug combination vs cabotegravir-based drug combination in virologically suppressed adults with HIV-1
FranceEfficacy and safety of votoplam in adults with Huntington’s disease: a randomized, double‑blind, placebo‑controlled Phase 3 trial
FranceEfficacy and Safety of Depemokimab for Early Intervention in Adults and Adolescents with Type 2 Asthma at Risk of Exacerbations
FranceCabozantinib Maintenance Therapy vs Best Supportive Care in Osteosarcoma Patients in Complete Remission or with Residual Disease after First‑Line Chemotherapy
FrancePhase 1b-2 Study of Safety and Preliminary Efficacy of LRK-4189 Alone or with Drug Combination in Patients with Solid Tumors
FranceThe busiest research cities in the country
What the registry says about research in the country
Advanced studies focusing on head and neck cancers, bladder cancer, and multiple myeloma. Novel therapeutic approaches combining immunotherapy with established treatments are being evaluated for improved patient outcomes.
Innovative combination therapies are being tested to enhance treatment efficacy while maintaining patient safety.
Comprehensive research into multiple sclerosis, essential tremor, and ADHD. Studies are evaluating both new and existing medications for improved symptom management and disease control.
Advanced neuroimaging techniques are being utilized to understand treatment effects on brain circuits.
Investigating new treatments for Crohn's disease, Sjögren's Syndrome, and Myasthenia Gravis. Research focuses on innovative therapeutic approaches including microbiota transplantation and targeted immunotherapies.
These trials aim to improve disease management and patient quality of life through targeted interventions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
